Abstracts

Antiretroviral Therapy Outcomes at 6 Months by HIV Recent Infection Classification, Rwanda 2021-2022

Background: Globally, over 25 countries have implemented HIV-1 recent infection surveillance to help detect and monitor recent infections among those newly diagnosed. As countries approach epidemic control and focus on early detection and life-long effective antiretroviral therapy (ART), we expect that an increasing proportion of persons newly diagnosed with HIV may be recently infected. However,…

COVID-19–Associated ART Disruptions and HIV Suppression: A Population-Based Study in Uganda

Background: Following confirmation of SARS-CoV-2 in Uganda, a national lockdown was imposed. Subsequent movement restrictions limited access to HIV services, including antiretroviral therapy (ART). We assessed the population burden of COVID-19-associated ART disruptions and their impacts on viral load suppression (VLS) among people living with HIV in Uganda. Methods: We used cross-sectional data collected between…

Impact of Proactive Adherence Interventions on HIV RNA Using Prescription Claims

Background: Adherence interventions are often implemented after virologic failure is identified. Antiretroviral therapy (ART) prescription claims data can guide adherence interventions for people with HIV (PWH) at risk of virologic failure. This study determined the effectiveness of using ART prescription claims to provide adherence interventions and achieve virologic suppression (VS). Methods: Participants were deemed eligible…

PrEP Persistence and Ongoing HIV Risk Among Patients Initiating PrEP at an Urban Malawi STI Clinic

Background: Persons presenting with sexually transmitted infections (STI) are a priority group for HIV prevention, including biomedical pre-exposure prophylaxis (PrEP). Longitudinal risk and persistent use of oral PrEP among STI patients in sub-Saharan Africa (SSA) has not been well characterized. Methods: We enrolled men and women ≥15 years presenting to an urban STI clinic who…

A Dual Prevention Pill for HIV and Pregnancy Prevention: A Pilot Study Among Young Women in Zimbabwe

Background: Effective use of oral pre-exposure prophylaxis (PrEP) has been sub-optimal among young women in sub-Saharan Africa at greatest risk of HIV. We hypothesized that a single dual prevention pill (DPP) combining PrEP and an oral contraceptive (OC) would be preferred, acceptable and increase PrEP adherence compared to PrEP alone. Methods: We enrolled 30 HIV-uninfected,…